Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy
暂无分享,去创建一个
M. Biffi | M. Bertini | M. Ziacchi | C. Rapezzi | L. Potena | I. Olivotto | A. Ferlini | L. Lovato | O. Leone | F. Gualandi | E. Biagini | C. Rossi | N. Galiè | G. Tini | M. Graziosi | C. Chiti | A. Berardini | F. Pasquale | V. Parisi | A. Caponetti | R. Ditaranto | M. Minnucci | V. Ferrara
[1] A. Mazzanti,et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. , 2020, International journal of cardiology.
[2] G. Aquaro,et al. EP News: Clinical , 2020, Heart Rhythm.
[3] S. Priori,et al. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy , 2020, Circulation.
[4] J. Serfaty,et al. Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies , 2020, ESC heart failure.
[5] D. Corrado,et al. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy , 2020, Journal of the American Heart Association.
[6] P. Elliott,et al. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study. , 2019, European heart journal cardiovascular Imaging.
[7] E. Behr,et al. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy , 2019, Circulation.
[8] R. Kim,et al. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement. , 2018, JACC. Cardiovascular imaging.
[9] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[10] S. Heymans,et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.
[11] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[12] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[13] H. Rehm,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[14] E. Arbustini,et al. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[15] P. Elliott,et al. Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study , 2011, Heart.
[16] M. Sheppard,et al. Prevalence of Desmosomal Protein Gene Mutations in Patients With Dilated Cardiomyopathy , 2010, Circulation. Cardiovascular genetics.
[17] Dudley J Pennell,et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.